100 mg Tabletten

DRUG3 trials

Sponsors

St Antonius Hospital, University Hospital Zurich, University Medical Center Hamburg-Eppendorf

Conditions

Acute ischemic strokeChronic coronary syndromeStable coronary artery diseaserelapsed/refractory acute myeloid leukemia

Phase 2

A PHASE I/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MEBENDAZOLE IN COMBINATION WITH LOW-DOSE ARA-C IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (MAIL)

CompletedCTIS2024-518363-36-00

University Medical Center Hamburg-Eppendorfrelapsed/refractory acute myeloid leukemia

End: 2025-08-21Target: 50Updated: 2025-02-10

Phase 3

MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study. An international, multicentre, randomised-controlled, two-arm, assessor-blinded trial.

Not yet recruitingCTIS2024-517600-11-01

University Hospital ZurichAcute ischemic stroke

Target: 190Updated: 2025-01-23

Phase 4

Pharmacodynamic Outcomes in patients with coronary artery disease undergoing Percutaneous coronary intervention treated with an individualized treatment STRATEGY (POPular STRATEGY PD)

RecruitingCTIS2023-504078-39-01

St Antonius HospitalChronic coronary syndrome, Stable coronary artery disease

Start: 2024-01-11Target: 88Updated: 2024-08-26